CPNE3

Chr 8

copine 3

Also known as: CPN3, PRO1071

CPNE3 encodes a calcium-dependent phospholipid-binding protein that contains C2 domains for membrane binding and facilitates cell migration through ERBB2-mediated pathways. Mutations cause autosomal recessive neurodevelopmental disorders with intellectual disability, seizures, and movement abnormalities. The gene shows minimal constraint against loss-of-function mutations, consistent with recessive inheritance patterns.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
8
Pubs (1 yr)
33
P/LP submissions
0%
P/LP missense
1.54
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryCPNE3
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
33 unique Pathogenic / Likely Pathogenic· 72 VUS of 140 total submissions
Some data sources returned errors (1)

pubtator: TimeoutError: The operation was aborted due to timeout

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.54LOEUF
pLI 0.000
Z-score -0.82
OE 1.16 (0.891.54)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.98Z-score
OE missense 1.16 (1.061.27)
329 obs / 282.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.16 (0.891.54)
00.351.4
Missense OE1.16 (1.061.27)
00.61.4
Synonymous OE0.98
01.21.6
LoF obs/exp: 35 / 30.1Missense obs/exp: 329 / 282.8Syn Z: 0.16
DN
0.6745th %ile
GOF
0.7127th %ile
LOF
0.3843th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

140 submitted variants in ClinVar

Classification Summary

Pathogenic33
VUS72
Likely Benign2
33
Pathogenic
72
VUS
2
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
33
0
33
Likely Pathogenic
0
0
0
0
0
VUS
0
64
8
0
72
Likely Benign
0
1
0
1
2
Benign
0
0
0
0
0
Total065411107

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CPNE3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →